课题基金 / 基金详情

项目摘要

项目成果

KARSTEN WEIS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请涉及广泛的挑战领域(06)使能技术和具体的挑战主题,06-GM-112:分子和细胞动力学技术。生物学研究中的一个中心问题是理解基因组是如何被解释来决定生物形式和功能的巨大多样性的。此外,为了剖析和预防人类疾病的发展,确定在解释遗传信息期间可能发生的不当管理是至关重要的。虽然基因表达调控的许多重要步骤都发生在转录水平,但越来越清楚的是,转录后处理对于精确控制真核细胞中的基因表达也是必不可少的。例如,RNA介导的沉默途径的发现控制着mRNA的翻译或衰退,并在生物发育或癌症等疾病的发展过程中发挥关键作用。然而,与我们对转录调控机制的出色理解相反,我们对转录后调控程序仍然知之甚少。这在一定程度上是因为缺乏能够让我们以动态和非侵入性方式分析转录后调控步骤的技术。在这一应用中,我们将解决这一挑战,并建议开发和应用新的标记方法,使我们能够在系统范围内以高灵敏度和不受细胞环境干扰的方式测量单个RNA和蛋白质的周转。这将首次使我们能够将转录过程中发生的变化与mRNA稳定性、翻译和蛋白质周转的测量相结合。总而言之,这将使我们能够对不同生长条件和不同细胞类型下的基因表达调控进行全面的概述。从长远来看,我的实验室将探索从这些研究中出现的新范式,并将阐明新的调控反应背后的分子机制。这些研究将提供对决定基因表达模式的细胞动力学的基本原理的关键洞察,并帮助我们理解人类疾病中发生的缺陷。 与公共健康相关:在所有真核生物中,对基因表达的严格调控对于控制细胞的增殖、分化或发育是必不可少的,基因表达程序的任何步骤中的错误都可能导致细胞死亡或疾病。控制基因表达的一个关键步骤是通过调节它们的衰变来控制mRNA和蛋白质的丰度。因此,更好地了解mRNA和蛋白质周转的调节对于理解基本的细胞过程和开发治疗人类疾病的新方法都是至关重要的。
英文摘要
DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (06) Enabling Technologies and specific Challenge Topic, 06-GM-112: Molecular and Cellular Dynamics Technologies. A central problem in biological research is to understand how the genome is interpreted to determine the large diversity of organismal form and function. In addition, it is critical to identify misregulations that can occur during the interpretation of the genetic information in order to dissect and prevent the development of human diseases. While it has been well established that many important steps in the regulation of gene expression occur at the level of transcription, it has become increasingly clear that posttranscriptional processing is also essential for the precise control of gene expression in eukaryotic cells. Examples include the discovery of RNA-mediated silencing pathways that control mRNA translation or decay and play critical roles during organismal development or during the development of diseases such as cancer. However, in contrast to our excellent understanding of transcriptional control mechanisms, very little is still known about post-transcriptional regulatory programs. This is in part due to the lack of technologies that would enable us to analyze post-transcriptional control steps in a dynamic and non-invasive fashion. In this application, we will address this challenge and propose the development and application of novel labeling methods that will allow us to measure on a system-wide level the turnover of individual RNAs and proteins with high sensitivity and without perturbation of the cellular environment. For the first time, this will allow us to integrate changes that occur in transcription with measurements of mRNA stability, translation and protein turnover. Together, this will allow us to develop a comprehensive overview of the regulation of gene expression under various growth conditions and in different cell types. In the long run, my laboratory will explore new paradigms that emerge from these studies and will elucidate the molecular mechanism underlying novel regulatory responses. These studies will provide critical insight into the fundamental principles that determine the cellular dynamics of gene expression patterns and help us to understand defects that occur in human diseases. PUBLIC HEALTH RELEVANCE: In all eukaryotes, the tight regulation of gene expression is essential for cells to control proliferation, differentiation or development, and errors in any step of the gene expression program can have severe consequences leading to cell death or disease. A critical step in the control of gene expression is the control of mRNA and protein abundance by the regulation of their decay. Therefore, a better understanding of the regulation of mRNA and protein turnover is essential both for the understanding of fundamental cellular processes and the development of novel therapies for human diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of gene-specific and genome-wide regulation of mRNA turnover
Spinning Disk Confocal Microscope for the University of California, Berkeley
Posttranscriptional regulation of gene expression in eukaryotes
Using Chemical Biology to Study the Small GTPase Ra(RMI)
海外基金